Galapagos - Intraday - We look to Sell a break of 40.98 (stop at 43.03)
Daily signals are bearish.
There is no clear indication that the downward move is coming to an end.
Trades at the lowest level in 38 weeks.
The previous low is located at 41.30.
A break of 41.00 is needed to confirm follow through negative momentum.
Our profit targets will be 36.33 and...
TLDR: targeting 80 if next pull back holds 56.
--
Galapagos has gained more than 50% nominally off the Dec '21 low, in a three waves structure.
While running into the 1.618 extension of the green circle i-ii, the technicals are becoming overbought.
With the next earning report within a month, it seems wise to take some profits off the tabel.
Further more, the 65...
We think Galapagos is undervalued at current levels. The price will be heading $240 soon.
Cup and Handle formation.
The RSI / MACD and volume showing signs of recovery from recent 60% correction.
First price target: $ 240
Second price target: $350 - $480 (2022/23)
Full year 2020 results:
18 Febuary 2021
Webcast 19 February 2021, 14.00 CET
Events:
January...
FDA provides preliminary approval for the drug filgotinib not approved, Galapagos will now assume full responsibility for filgotinib in Europe. Gilead will pay EUR 160 million to Galapagos to accelerate commercial activities in Europe. The gap from 19 march 2019 is filled....ready for the turn up..... what do you think?
We are currently in the middle of the month and Christmas is coming. This is a quiet period and normally there will be little movement here. We can therefore conclude that the biggest moves of the month have now come to an end within a week. Assuming that the price closes around this value at the end of the month, we see a pretty good respectation around 200. This...
